Free Trial
→ Altucher: Turn $900 into $108,000 in just 12 months? (From Paradigm Press) (Ad)
LON:HLN

Haleon 2/28/2025 Earnings Report

Haleon logo
GBX 398 -0.40 (-0.10%)
As of 06:20 AM Eastern
Earnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 15.80
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Date
2/28/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Haleon plc (LON:HLN) Insider Asmita Dubey Buys 15,424 Shares
May 4 at 1:19 AM | americanbankingnews.com
Haleon climbs Tuesday, outperforms market
April 9, 2025 | marketwatch.com
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
May 6, 2025 | Golden Portfolio (Ad)
Haleon slips Monday, underperforms market
March 24, 2025 | marketwatch.com
Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus
March 23, 2025 | msn.com
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)
March 22, 2025 | markets.businessinsider.com
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other. Within these categories, there are long standing-brands – such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, paradontax and Centrum, which are used and trusted by millions of consumers around the world. These brands are built on trusted science, innovation and deep human understanding.

View Haleon Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles